These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


272 related items for PubMed ID: 22211457

  • 1. A rest period before agitation may improve some in vitro apheresis platelet parameters during storage.
    Skripchenko A, Myrup A, Awatefe H, Thompson-Montgomery D, Wagner SJ.
    Transfusion; 2012 Jul; 52(7):1433-8. PubMed ID: 22211457
    [Abstract] [Full Text] [Related]

  • 2. A rest period does not affect in vitro storage properties in apheresis platelets collected from the buffy coat layer.
    Wagner SJ, Seetharaman S, Kurtz J.
    Transfusion; 2012 Nov; 52(11):2427-31. PubMed ID: 22452313
    [Abstract] [Full Text] [Related]

  • 3. The influence of simulated shipping conditions (24- or 30-hr interruption of agitation) on the in vitro properties of apheresis platelets during 7-day storage.
    Wagner SJ, Vassallo R, Skripchenko A, Einarson M, Seetharaman S, Moroff G.
    Transfusion; 2008 Jun; 48(6):1072-80. PubMed ID: 18373503
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the in vitro properties of apheresis platelets during 7-day storage after interrupting agitation for one or three periods.
    Wagner SJ, Vassallo R, Skripchenko A, Einarson M, Seetharaman S, Moroff G.
    Transfusion; 2008 Dec; 48(12):2492-500. PubMed ID: 18764829
    [Abstract] [Full Text] [Related]

  • 5. Storage of aliquots of apheresis platelets for neonatal use in syringes with and without agitation.
    Diab Y, Wong E, Criss VR, Moroff G, Wagner SJ, Luban NL.
    Transfusion; 2011 Dec; 51(12):2642-6. PubMed ID: 21745210
    [Abstract] [Full Text] [Related]

  • 6. Periods without agitation diminish platelet mitochondrial function during storage.
    Skripchenko A, Myrup A, Thompson-Montgomery D, Awatefe H, Moroff G, Wagner SJ.
    Transfusion; 2010 Feb; 50(2):390-9. PubMed ID: 19874561
    [Abstract] [Full Text] [Related]

  • 7. Maintenance of platelet in vitro properties during 7-day storage in M-sol with a 30-hour interruption of agitation.
    Wagner SJ, Myrup A, Awatefe H, Thompson-Montgomery D, Hirayama J, Skripchenko A.
    Transfusion; 2008 Dec; 48(12):2501-607. PubMed ID: 18764828
    [Abstract] [Full Text] [Related]

  • 8. In vitro variables of apheresis platelets are stably maintained for 7 days with 5% residual plasma in a glucose and bicarbonate salt solution, PAS-5.
    Radwanski K, Wagner SJ, Skripchenko A, Min K.
    Transfusion; 2012 Jan; 52(1):188-94. PubMed ID: 21790624
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the automated collection and extended storage of apheresis platelets in additive solution.
    Johnson L, Winter KM, Hartkopf-Theis T, Reid S, Kwok M, Marks DC.
    Transfusion; 2012 Mar; 52(3):503-9. PubMed ID: 21880041
    [Abstract] [Full Text] [Related]

  • 10. Platelet capacity of various platelet pooling systems for buffy coat-derived platelet concentrates.
    Dijkstra-Tiekstra MJ, Kuipers W, Setroikromo AC, de Wildt-Eggen J.
    Transfusion; 2008 Oct; 48(10):2114-21. PubMed ID: 18647365
    [Abstract] [Full Text] [Related]

  • 11. Buffy-coat platelet variables and metabolism during storage in additive solutions or plasma.
    Zhang JG, Carter CJ, Culibrk B, Devine DV, Levin E, Scammell K, Weiss S, Gyongyossy-Issa MI.
    Transfusion; 2008 May; 48(5):847-56. PubMed ID: 18298601
    [Abstract] [Full Text] [Related]

  • 12. The role of bicarbonate in platelet additive solution for apheresis platelet concentrates stored with low residual plasma.
    Radwanski K, Min K.
    Transfusion; 2013 Mar; 53(3):591-9. PubMed ID: 22725609
    [Abstract] [Full Text] [Related]

  • 13. Paired in vitro and in vivo comparison of apheresis platelet concentrates stored in platelet additive solution for 1 versus 7 days.
    Shanwell A, Diedrich B, Falker C, Jansson B, Sandgren P, Sundkvist L, Svensson L, Vesterinen M, Gulliksson H.
    Transfusion; 2006 Jun; 46(6):973-9. PubMed ID: 16734814
    [Abstract] [Full Text] [Related]

  • 14. Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage.
    Skripchenko A, Kurtz J, Moroff G, Wagner SJ.
    Transfusion; 2008 Jul; 48(7):1469-77. PubMed ID: 18482181
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of in vitro storage properties of apheresis platelets suspended in a bicarbonate-containing additive solution with low levels of plasma and stored with a 24-hour interruption of agitation.
    Skripchenko A, Turgeon A, Thompson-Montgomery D, Awatefe H, Wagner SJ.
    Vox Sang; 2014 May; 106(4):337-43. PubMed ID: 24330192
    [Abstract] [Full Text] [Related]

  • 16. Value of calcium and phosphate in a bicarbonate-containing platelet additive solution with low plasma levels in maintaining key in vitro platelet storage parameters.
    Skripchenko A, Turgeon A, Thompson-Montgomery D, Awatefe H, Wagner SJ.
    Transfusion; 2017 Feb; 57(2):349-356. PubMed ID: 27859382
    [Abstract] [Full Text] [Related]

  • 17. Storage of platelet concentrates from pooled buffy coats made of fresh and overnight-stored whole blood processed on the novel Atreus 2C+ system: in vitro study.
    Sandgren P, Callaert M, Shanwell A, Gulliksson H.
    Transfusion; 2008 Apr; 48(4):688-96. PubMed ID: 18194379
    [Abstract] [Full Text] [Related]

  • 18. Quantitation of coated platelet potential during collection, storage, and transfusion of apheresis platelets.
    Charania R, Smith J, Vesely SK, Dale GL, Holter J.
    Transfusion; 2011 Dec; 51(12):2690-4. PubMed ID: 21645004
    [Abstract] [Full Text] [Related]

  • 19. Calcium is a key constituent for maintaining the in vitro properties of platelets suspended in the bicarbonate-containing additive solution M-sol with low plasma levels.
    Wagner SJ, Skripchenko A, Myrup A, Thompson-Montgomery D, Awatefe H, Moroff G.
    Transfusion; 2010 May; 50(5):1028-35. PubMed ID: 20030790
    [Abstract] [Full Text] [Related]

  • 20. In vitro platelet quality in storage containers used for pediatric transfusions.
    Weiss S, Scammell K, Levin E, Culibrk B, Zolfaghari S, Gyöngyössy-Issa MI, Acker JP.
    Transfusion; 2012 Aug; 52(8):1703-14. PubMed ID: 22257224
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.